RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Frederick P. Bellinger and Daniel Torres.
Connection Strength

2.007
  1. Torres DJ, Yorgason JT, Andres MA, Bellinger FP. Methamphetamine Exposure During Development Causes Lasting Changes to Mesolimbic Dopamine Signaling in Mice. Cell Mol Neurobiol. 2022 Oct; 42(7):2433-2438.
    View in: PubMed
    Score: 0.829
  2. Torres DJ, Yorgason JT, Mitchell CC, Hagiwara A, Andres MA, Kurokawa S, Steffensen SC, Bellinger FP. Selenoprotein P Modulates Methamphetamine Enhancement of Vesicular Dopamine Release in Mouse Nucleus Accumbens Via Dopamine D2 Receptors. Front Neurosci. 2021; 15:631825.
    View in: PubMed
    Score: 0.818
  3. Kiyohara ACP, Torres DJ, Hagiwara A, Pak J, Rueli RHLH, Shuttleworth CWR, Bellinger FP. Selenoprotein P Regulates Synaptic Zinc and Reduces Tau Phosphorylation. Front Nutr. 2021; 8:683154.
    View in: PubMed
    Score: 0.208
  4. Rueli RH, Torres DJ, Dewing AS, Kiyohara AC, Barayuga SM, Bellinger MT, Uyehara-Lock JH, White LR, Moreira PI, Berry MJ, Perry G, Bellinger FP. Selenoprotein S Reduces Endoplasmic Reticulum Stress-Induced Phosphorylation of Tau: Potential Role in Selenate Mitigation of Tau Pathology. J Alzheimers Dis. 2017; 55(2):749-762.
    View in: PubMed
    Score: 0.152
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support